海外の治験の状況「前立腺癌」での検索結果
167件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- Prospective Analysis of Robot-Assisted Surgery
- Esophageal Cancer;Gastric Cancer;Pancreatic Cancer;Rectal Cancer;Bladder Cancer;Prostate Cancer;Renal Cancer;Uterus Cancer;Head and Neck Cancer;Lung Cancer
- Brazil
- 2014-09-03
Not Recruiting
- INTERNATIONAL MULTICENTER STUDY, DOUBLE-BLIND, RANDOMIZED, PHASE III OF SATRAPLATIN PLUSBO PLUSBO OR PREDNISONE PLUSBO IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER PREVIOUSLY TREATED WITH A REGIME OF CYTOXIC CHEMOTHERAPY GPC SAT3-03-01
- -C61 Malignant neoplasm of prostate Malignant neoplasm of prostate;Malignant neoplasm of prostate
- Canada, Japan, Peru, Switzerland, United Kindgdom, United States
- 2004-03-04
Not recruiting
- Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
- Breast Cancer;Cognitive/Functional Effects;Colorectal Cancer;Lung Cancer;Pain;Prostate Cancer;Psychosocial Effects of Cancer and Its Treatment
- Peru, Puerto Rico, United States
- 2006-03-15
Not Recruiting
- CLINICAL STUDY PHASE II, RANDOMIZED, OF THREE BRANCHES OF IROFULVEN / PREDNISONE, IROFULVEN / CAPECITABINE / PREDNISONE OR MITOXANTRONE / PREDNISONE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER PREVIOUSLY TREATED WITH DOCETAXEL
- -C61 Malignant neoplasm of prostate Malignant neoplasm of prostate;Malignant neoplasm of prostate
- Peru
- 2004-07-09
Recruiting
- Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
- Cushing's Disease;Acromegaly;Neuroendocrine Tumors;Pituitary Tumors;Ectopic ACTH Secreting (EAS) Tumors;Dumping Syndrome;Prostate Cancer;Melanoma Negative for bRAF;Melanoma Negative for nRAS
- Argentina, Belgium, Brazil, Bulgaria, Canada, China, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, Peru, Poland, Portugal, Romania, Russian Federation, Spain, Switzerland, Taiwan, Thailand, Turkey, United States
- 2013-02-15
Not Recruiting
- A Double-blind, Randomised, Multiple Dose, Phase III, Multicentre Study of Alpharadin in the Treatment of Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases
- Hormone Refractory Prostate Cancer # Bone Metastases;C61 - Malignant neoplasm of prostate;C79.5 - Secondary malignant neoplasm of bone and bone marrow
- Australia, Belgium, Brazil, Canada, Czech Republic, France, Germany, Hong Kong, Israel, Italy, Netherlands, Norway, Poland, Singapore, Slovakia, Spain, Sweden, United Kingdom, United States
- 2012-08-31
Authorised
- A clinical trial to assess the long term safety of radium-223 dichloride
- Castrate Resistant Prostate Cancer/Hormone-Refractory Prostate Cancer, breast cancer or multiple myeloma patients with bone metastasis MedDRA version: 20.1 Level: LLT Classification code 10036916 Term: Prostate cancer stage D System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.1 Level: PT Classification code 10055113 Term: Breast cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Brazil, Canada, Chile, Czech Republic, Finland, France, Germany, Israel, Italy, Japan, Korea, Democratic People's Republic of, Netherlands, Norway, Poland, Russian Federation, Singapore, Spain, Sweden, Taiwan, United States
- 2014-10-24
Not Recruiting
- An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
- Metastatic Breast Cancer [F] # Advanced Breast Cancer # Metastatic Castration Resistant Prostate Cancer # Metastatic Renal Cell Cancer # Non-Small Cell Lung Cancer # Thyroid Cancer # Advanced/Metastatic Non-Small Cell Lung Cancer # Advanced Gastric Cancer # Gastrointestinal Stromal Tumor # Hepatocellular Carcinoma # Pancreatic Islet Cell Carcinoma # Pancreatic Neuroendocrine Tumor;C00-C97 - Malignant neoplasms
- Argentina, Australia, Belgium, Brazil, Canada, Colombia, France, Germany, Hong Kong, Korea, Republic of, Mexico, Philippines, Singapore, Spain, Taiwan, Province of China, United Kingdom, United States
- 2012-06-21
Not recruiting
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
- Metastatic Breast Cancer [F];Advanced Breast Cancer;Metastatic Castration Resistant Prostate Cancer;Metastatic Renal Cell Cancer;Non-Small Cell Lung Cancer;Thyroid Cancer;Advanced/Metastatic Non-Small Cell Lung Cancer;Advanced Gastric Cancer;Gastrointestinal Stromal Tumor;Hepatocellular Carcinoma;Pancreatic Islet Cell Carcinoma;Pancreatic Neuroendocrine Tumor;Metastatic Breast Cancer [F];Advanced Breast Cancer;Metastatic Castration Resistant Prostate Cancer;Metastatic Renal Cell Cancer;Non-Small Cell Lung Cancer;Thyroid Cancer;Advanced/Metastatic Non-Small Cell Lung Cancer;Advanced Gastric Cancer;Gastrointestinal Stromal Tumor;Hepatocellular Carcinoma;Pancreatic Islet Cell Carcinoma;Pancreatic Neuroendocrine Tumor;Metastatic Breast Cancer [F];Advanced Breast Cancer;Metastatic Castration Resistant Prostate Cancer;Metastatic Renal Cell Cancer;Non-Small Cell Lung Cancer;Thyroid Cancer;Advanced/Metastatic Non-Small Cell Lung Cancer;Advanced Gastric Cancer;Gastrointestinal Stromal Tumor;Hepatocellular Carcinoma;Pancreatic Islet Cell Carcinoma;Pancreatic Neuroendocrine Tumor;Metastatic Breast Cancer [F];Advanced Breast Cancer;Metastatic Castration Resistant Prostate Cancer;Metastatic Renal Cell Cancer;Non-Small Cell Lung Cancer;Thyroid Cancer;Advanced/Metastatic Non-Small Cell Lung Cancer;Advanced Gastric Cancer;Gastrointestinal Stromal Tumor;Hepatocellular Carcinoma;Pancreatic Islet Cell Carcinoma;Pancreatic Neuroendocrine Tumor
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Colombia, France, Germany, Hong Kong, India, Korea, Republic of, Mexico, Netherlands, Peru, Philippines, Singapore, Spain, Taiwan, United Kingdom, United States
- 2007-01-26
Not Recruiting
- PARALLEL GROUP SINGLE BLIND STUDY TO COMPARE THE PHARMACOKINETIC PROFILES AND PHARMACODYNAMIC RESPONSE OF A NEW DEPOT FORMULATION OF GOSERELIN ACETATE CAPSULE/IMPLANT FOR SUBCUTANEOUS INJECTION, PEPTI 10.8 MG, TO ZOLADEX 10.8 MG CAPSULE/IMPLANT IN AMBULATORY PATIENTS WITH ADVANCED CARCINOMA OF THE PROSTATE.
- -C61 Malignant neoplasm of prostate Malignant neoplasm of prostate;C61 ;Malignant neoplasm of prostate
- Canada, Chile, Colombia, Peru, Serbia, Ukraine
- 2019-06-17
